Physician profile
Craig S Feaster
NPI 1912905795
$18,287.74
in general payments reported to CMS, 2019-2025
24 companies · $1,455 in 2025
The $1,455 reported for 2025 was more than what 90% of Child & Adolescent Psychiatry providers received nationally (typical 2025 total: $132).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $348 · 2020: $162 · 2021: $391 · 2022: $11K · 2023: $4,349 · 2024: $1,016 · 2025: $1,455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,171 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,880 · Consulting Fee: $640 · Travel and Lodging: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,170.96 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,880.00 |
| Consulting Fee | $640.00 |
| Travel and Lodging | $128.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $14,193.14 | 2022-2023 | Azstarys |
| Supernus Pharmaceuticals, INC. | $742.63 | 2021-2025 | Qelbree, Qelbree |
| Otsuka America Pharmaceutical, INC. | $642.29 | 2019-2025 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Janssen Pharmaceuticals, INC | $500.94 | 2019-2025 | Spravato, Invega Sustenna, Invega Trinza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $491.36 | 2020-2025 | Caplyta |
| Alkermes, INC. | $398.96 | 2022-2025 | Lybalvi, Aristada |
| E.R. Squibb & Sons, L.L.C. | $226.87 | 2024-2025 | Cobenfy |
| Ironshore Pharmaceuticals INC. | $226.79 | 2019-2023 | Jornay Pm |
| Abbvie INC. | $220.57 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $100.78 | 2025 | Jornay Pm |
| Axsome Therapeutics, INC. | $68.01 | 2022-2025 | Auvelity |
| Jazz Pharmaceuticals INC. | $62.48 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $52.65 | 2020-2025 | Austedo Xr, Austedo Xr |
| Lundbeck LLC | $50.40 | 2019-2025 | Rexulti |
| Neurocrine Biosciences, INC. | $46.16 | 2020-2025 | Ingrezza |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $44.98 | 2019-2021 | |
| Eisai INC. | $41.58 | 2020-2021 | |
| Shire North American Group INC | $37.53 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $33.07 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $29.06 | 2019-2022 | |
| Idorsia Pharmaceuticals US INC | $24.97 | 2023 | Quviviq |
| Noven Therapeutics, LLC | $23.53 | 2024 | Secuado, Xelstrym |
| Neuronetics, INC. | $17.02 | 2024 | Neurostar Tms Therapy System |
| Merck Sharp & Dohme LLC | $11.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Feaster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.